Advertisement
Canada markets close in 31 minutes
  • S&P/TSX

    21,796.05
    +87.61 (+0.40%)
     
  • S&P 500

    4,968.52
    -42.60 (-0.85%)
     
  • DOW

    37,962.35
    +186.97 (+0.49%)
     
  • CAD/USD

    0.7273
    +0.0009 (+0.13%)
     
  • CRUDE OIL

    83.26
    +0.53 (+0.64%)
     
  • Bitcoin CAD

    88,453.70
    +1,331.97 (+1.53%)
     
  • CMC Crypto 200

    1,382.19
    +69.57 (+5.30%)
     
  • GOLD FUTURES

    2,409.90
    +11.90 (+0.50%)
     
  • RUSSELL 2000

    1,939.84
    -3.12 (-0.16%)
     
  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     
  • NASDAQ

    15,290.46
    -311.04 (-1.99%)
     
  • VOLATILITY

    18.86
    +0.86 (+4.77%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     

What’s behind Insys Therapeutics’ Legal Tangles?

What’s behind Insys Therapeutics’ Legal Tangles?

Thus, interaction with government agencies occurs regularly. Insys (INSY) has been a part of several government investigations recently. Insys received a subpoena in December 2013 from the inspector general of HHS for an investigation of potential violations that involved HHS programs.